Growth Metrics

Armata Pharmaceuticals, Inc. (ARMP) Shares Outstanding (Diluted Average) (2016 - 2018)

Armata Pharmaceuticals' Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $4.7 million for Q3 2018.

  • For Q3 2018, Shares Outstanding (Diluted Average) fell 15.69% year-over-year to $4.7 million; the TTM value through Sep 2018 reached $4.7 million, down 15.69%, while the annual FY2017 figure was $6.6 million, 568.21% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2018 was $4.7 million at Armata Pharmaceuticals, roughly flat from $4.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $7.5 million in Q2 2015 and bottomed at $876806.0 in Q2 2016.
  • The 5-year median for Shares Outstanding (Diluted Average) is $5.5 million (2017), against an average of $4.6 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) tumbled 94.18% in 2014 before it surged 568.21% in 2017.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.9 million in 2014, then fell by 1.25% to $5.8 million in 2015, then plummeted by 83.08% to $983846.0 in 2016, then soared by 568.21% to $6.6 million in 2017, then dropped by 29.23% to $4.7 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Shares Outstanding (Diluted Average) are $4.7 million (Q3 2018), $4.7 million (Q2 2018), and $6.6 million (Q4 2017).